Pfizer: Pay

Pfizer paid its one named executive on file $9.4M in FY2025 (Dec).

PayNo stock prices for these years
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

A. BourlaChairman and Chief Executive Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
4 years
A. MalikChief U.S. Commercial Officer, EVP
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
3 years
D. DentonChief Financial Officer, EVP
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
3 years
C. BoshoffChief Scientific Officer and President, Research & Development
FY2024 (Dec)
1 year
D. LanklerGeneral Counsel, EVP
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
4 years

CEO pay against the pay peers

No CEO pay of the disclosed peers is on file for FY2015 (Dec).

  1. 1PfizerNot disclosed
  2. 2AbbVieNot disclosed
  3. 3AmgenNot disclosed
  4. 4AstraZenecaNot disclosed
  5. 5Bristol Myers SquibbNot disclosed
  6. 6Eli LillyNot disclosed
  7. 7GlaxoSmithKlineNot disclosed
  8. 8Johnson & JohnsonNot disclosed
  9. 9MerckNot disclosed
  10. 10NovartisNot disclosed
  11. 11RocheNot disclosed
  12. 12SanofiNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.